Last reviewed · How we verify
photosensitizer(photofrin)
At a glance
| Generic name | photosensitizer(photofrin) |
|---|---|
| Also known as | photofrin |
| Sponsor | The First Affiliated Hospital of Henan University of Science and Technology |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction (NA)
- Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
- Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer (PHASE3)
- Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma (PHASE2, PHASE3)
- A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: